Discount agreements for 12 active ingredients

13.10.2009 17:39

Sanofi-aventis and Winthrop conclude exclusive discount agreements with AOK

Sanofi-aventis, including its generics subsidiary Winthrop, has been awarded a significant portion of the contracts for 64 active ingredients in the current AOK tender. Effective June 1, 2009, AOK concluded exclusive discount agreements with sanofi-aventis/Winthrop for 12 active ingredients in accordance with Section 130a, Paragraph 8 of the German Social Code (SGB V).

These contracts apply exclusively to 10 substances throughout Germany: alfuzosin, amisulpride, glimepiride, ramipril, ramipril + HCT, bisoprolol, ibuprofen, lisinopril + HCT, nifedipine, and verapamil. Sanofi-Aventis/Winthrop received the exclusive contract for a total of seven lots for the following two substances: molsidomine and trimipramine.

Sanofi-aventis/Winthrop thus concludes contracts for 57 of a total of 315 awarded lots and is one of AOK's most important partners in this year's nationwide tender. The total sales volume of these awards at AOK in 2008 amounted to approximately €132 million based on manufacturer's selling prices. Over 23 million AOK members with statutory health insurance thus have access to discounted products from Sanofi-aventis/Winthrop.